Nath Bio-Genes Standalone September 2025 Net Sales at Rs 39.77 crore, up 23.54% Y-o-Y
Broker Research
November 19, 2025 / 12:46 IST
Reported Standalone quarterly numbers for Nath Bio-Genes are: Net Sales at Rs 39.77 crore in September 2025 up 23.54% from Rs. 32.19 crore in September 2024. Quarterly Net Profit at Rs. 4.20 crore in September 2025 up 45.38% from Rs. 2.89 crore in September 2024. EBITDA stands at Rs. 9.13 crore in September 2025 up 37.71% from Rs. 6.63 crore in September 2024. Nath Bio-Genes EPS has increased to Rs. 2.16 in September 2025 from Rs. 1.46 in September 2024. Nath Bio-Genes shares closed at 163.53 on November 17, 2025 (NSE) and has given -14.02% returns over the last 6 months and -6.83% over the last 12 months.
| Nath Bio-Genes | | Standalone Quarterly Results | in Rs. Cr. |
|
Story continues below Advertisement
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 39.77 | 280.17 | 32.19 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 39.77 | 280.17 | 32.19 | | EXPENDITURE | | Consumption of Raw Materials | 20.55 | 108.24 | -0.52 | | Purchase of Traded Goods | 0.28 | 4.35 | 3.75 | | Increase/Decrease in Stocks | -7.95 | 23.80 | 9.24 | | Power & Fuel | -- | -- | -- | | Employees Cost | 9.66 | 9.05 | 8.17 | | Depreciation | 0.98 | 0.98 | 0.83 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 10.05 | 95.83 | 5.00 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 6.21 | 37.93 | 5.74 | | Other Income | 1.93 | 1.76 | 0.07 | | P/L Before Int., Excpt. Items & Tax | 8.15 | 39.69 | 5.80 | | Interest | 3.30 | 2.89 | 2.94 | | P/L Before Exceptional Items & Tax | 4.84 | 36.80 | 2.86 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 4.84 | 36.80 | 2.86 | | Tax | 0.64 | 0.66 | -0.03 | | P/L After Tax from Ordinary Activities | 4.20 | 36.14 | 2.89 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | 2.06 | -- | | Net Profit/(Loss) For the Period | 4.20 | 38.21 | 2.89 | | Equity Share Capital | 19.00 | 19.00 | 19.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 2.16 | 20.06 | 1.46 | | Diluted EPS | 2.16 | 20.06 | 1.46 | | EPS After Extra Ordinary | | Basic EPS | 2.16 | 20.06 | 1.46 | | Diluted EPS | 2.16 | 20.06 | 1.46 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
